Reflecting growing concern over the opioid crisis, Walgreens Boots Alliance (WBA) shareholders voted in favor of a proposal calling for the company to issue a regular report on how it manages the risk of distributing these addictive prescription painkillers, according to preliminary results.
The proposal requires the pharmacy chain to prepare a report by June 30 detailing any changes the company has made to corporate governance since 2012 concerning opioid sales. The report should include specific board oversight of programs pertaining to opioids and whether and how executive compensation has been changed to reflect incentives.
About the Author Reprints
